Amazon Web Services (AWS) announced this Tuesday the launch of its AI bio tool, Amazon Bio Discovery, to accelerate the early-stage process of drug discovery in the pharmaceutical industry. The application aims to help scientists design and test novel drugs in a fast and secure way.
Amazon Bio Discovery enables scientists to run complex computational workflows through more than 40 AI-specialized foundational models, trained on a wide range of biological datasets.
These models generate and evaluate potential drug molecules, alongside AI agents that help scientists to select models, optimize inputs and evaluate candidates according to their research.
Researchers can send the selected candidate list to integrated lab partners for synthesis and testing, and the results are sent back to the application for analysis and model refinement, creating what AWS calls the lab-in-the-loop.
